Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1968)
Long acting neurolep ~ ics . II . Pilot study of pimozide
M. Herman, S. Nagler (1954)
Psychoses due to amphetamine.The Journal of nervous and mental disease, 120 3-4
J. Brugmans (1968)
A multicentric clinical evaluation of pimozide. Preliminary report.Acta neurologica et psychiatrica Belgica, 68 12
M. Wallach, B. Angrist, S. Gershon (1971)
The comparison of the stereotyped behavior-inducing effects of d- and l-amphetamine in dogs.Communications in behavioral biology. Part A: [Original articles], 6 2
P. Janssen (1967)
The pharmacology of haloperidol.International journal of neuropsychiatry, 3
V. Lotti, C. Porter (1970)
Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.The Journal of pharmacology and experimental therapeutics, 172 2
R. Klingenstein, M. Wallach, S. Gershon (1973)
A comparison of pimozide and thioridazine as antagonists of amphetamine-induced stereotyped behavior in dogs.Archives internationales de pharmacodynamie et de therapie, 203 1
M. Wallach, S. Gershon (1971)
A neuropsychopharmacological comparison of d-amphetamine, L-dopa and cocaine.Neuropharmacology, 10 6
B. Angrist, S. Gershon (1970)
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.Biological psychiatry, 2 2
M. Wallach, S. Gershon (1972)
The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.European journal of pharmacology, 18 1
A. Horn, S. Snyder (1971)
Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs.Proceedings of the National Academy of Sciences of the United States of America, 68 10
Paul Janssen, C. Niemegeers, Schell Kh (1965)
IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.Arzneimittel-Forschung, 15
F. Hauschild (1938)
Zur Pharmakologie des 1-Phenyl-2-methylaminopropans (Pervitin)Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 191
(1968)
The clinical efficacy of pimozide in chronic psychotic patients
E. Ellinwood (1967)
AMPHETAMINE PSYCHOSIS: I. DESCRIPTION OF THE INDIVIDUALS AND PROCESSThe Journal of NERVOUS and MENTAL DISEASE, 144
R. Fog (2005)
Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugsPsychopharmacologia, 14
(1967)
Is it possible to predict the clinical effects of neuroleptie drugs (major tranquillizers) from animal date? Arzneimittel-Forseh
G. Chouinard, H. Lehmann, T. Ban (1970)
Pimozide in the treatment of chronic schizophrenic patients.Current therapeutic research, clinical and experimental, 12 9
A. Randrup, I. Munkvad (1966)
Role of Catecholamines in the Amphetamine Excitatory ResponseNature, 211
J. Kramer (1969)
Introduction to Amphetamine AbuseJournal of Psychoactive Drugs, 2
(1972)
Antagonism of stereotypy in dogs by thioridazine and pimozide
(1970)
Psychosis induced by the administration of d-amphetamine to human volunteers
(1970)
Drug induced stereotyped behavior and its antagonism in dogs
R. Fog, A. Randrup, H. Pakkenberg (2004)
Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviourPsychopharmacologia, 11
S. Snyder, K. Taylor, J. Coyle, J. Meyerhoff (1970)
The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs.The American journal of psychiatry, 127 2
P. Janssen, C. Niemegeers, K. Schellekens, A. Dresse, F. Lenaerts, A. Pinchard, W. Schaper, J. Nueten, F. Verbruggen (1968)
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.Arzneimittel-Forschung, 18 3
(1969)
Clinical and medico-criminological aspects of addiction to central stimulating drugs
E. Schelkunov (1967)
Adrenergic Effect of Chronic Administration of NeurolepticsNature, 214
A. Ernst, P. Smelik (1966)
Site of action of dopamine and apomorphine on compulsive gnawing behaviour in ratsExperientia, 22
Paul Janssen, Carlos Niemegeers, Schell Kh (1966)
Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?Arzneimittel-Forschung, 16 3
J. Bobon, A. Pinchard, F. Goffioul, A. Devroye, D. Bobon, M. Korn (1968)
[Long-acting neuroleptics. I. Pilot study of clofluperol (R9298)].Acta neurologica et psychiatrica Belgica, 68 2
J. Scheel‐Krüger (1971)
Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.European journal of pharmacology, 14 1
E. Ellinwood (1967)
Amphetamine psychosis : description of the individuals and processesJournal of Nervous and Mental Disease, 144
M. Peng (1963)
LOCUS OF EMETIC ACTION OF EPINEPHRINE AND DOPA IN DOGSJournal of Pharmacology and Experimental Therapeutics, 139
B. Angrist, B. Shopsin, S. Gershon (1971)
Comparative Psychotomimetic Effects of Stereoisomers of AmphetamineNature, 234
D. Young, W. Scoville (1938)
Paranoid Psychosis in Narcolepsy and the Possible Danger of Benzedrine TreatmentMedical Clinics of North America, 22
A. Randrup, I. Munkvad (1968)
Behavioural Stereotypies Induced by Pharmacological AgentsPharmacopsychiatrie, 1
J. Scheel‐Krüger, A. Randrup (1967)
Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline.Life sciences, 6 13
R. Pinder, D. Buxton, D. Green (1971)
On the dopamine‐like action of apomorphineJournal of Pharmacy and Pharmacology, 23
Å. Bertler, Elsa Rosengren (1959)
Occurrence and distribution of dopamine in brain and other tissuesExperientia, 15
C. Amsler (1923)
Beiträge zur Pharmakologie des GehirnsArchiv für experimentelle Pathologie und Pharmakologie, 97
213 26 26 2 2 John Rotrosen Marshall B. Wallach Burton Angrist Samuel Gershon Neuropsychopharmacology Research Unit, Department of Psychiatry New York University Medical Center 10016 New York New York USA Abstract Apomorphine was administered to dogs 1, 3 and 20 h after pretreatment with thioridazine, haloperidol or pimozide. The dogs were observed for emesis, stereotypy and side effects of the neuroleptics. All three neuroleptics effectively blocked emesis and stereotypy; haloperidol in doses as low as 0.0125 mg/kg for stereotypy and 0.050 mg/kg for emesis; pimozide, 0.025 mg/kg for stereotypy, and 0.00625 mg/kg for emesis; and thioridazine, 4.0 mg/kg for both effects. Haloperidol 0.050 mg/kg blocked emesis and stereotypy at 1 h, but the same dose of pimozide blocked only emesis at this time. Threshold doses (0.0125 mg/kg) of haloperidol blocked stereotypy but not emesis, whereas the same dose of pimozide blocked emesis but not stereotypy. A marked tremor and a gnawing syndrome were seen with haloperidol 0.050 mg/kg, but did not appear with pimozide until higher doses were administered; these side effects were not observed with thioridazine. The findings support a dopaminergic mechanism for apomorphine induced stereotypy in dogs. Differences in onset of pimozide and haloperidol suggest different permeabilities of the drugs through the blood brain barrier, as well as differences in accessibility of the chemoreceptor trigger zone and corpus striatum to circulating drugs. The different effects of threshold doses of pimozide and haloperidol may be explained by postulating the existence of two dopamine receptors.
Psychopharmacology – Springer Journals
Published: Jun 1, 1972
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.